Navigation Links
Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
Date:7/25/2018

Almac Clinical Technologies, the global leader in technology-enabled solutions for managing clinical trial patient and supplies data through its flagship IXRS® 3 Interactive Response Technology (IRT) debuts a first-in-industry podcast series entitled, “Spotlight on IRT: Best Practices.”

This podcast features both Almac thought leaders and outside experts discussing best practices relating to IRT, protocol changes, regulatory audits and the most current innovations in order to improve costs, safety and efficiencies in today’s complex clinical trials. The podcast homepage resides on the resource-filled Almac Clinical University and offers the listener the opportunity to submit questions, comments and/or a speaker for future episodes.

“Almac Clinical Technologies has been the leading partner in providing solutions and solving the challenges that occur in today’s dynamic global clinical trial landscape. Too often we see clients relying on legacy processes out of familiarity and forget to consider alternatives that may prove to be more efficient ways to approach a problem. Our intent is to shed light on some of the problem areas we see our clients facing on a regular basis, and suggest proactive and holistic solutions which can be readily implemented to ensure continued success,” said Valarie Higgins, President and Managing Director of Almac Clinical Technologies.

Matt Lowrie, Almac Clinical Technologies’ Quality Assurance Group Manager, who has 15+ years of hosting and managing regulatory agency inspections and effectively answering demands for hundreds of trials, serves as host for the series. The “Spotlight on IRT: Best Practices” podcast is free to access, available on iTunes®, Google Play™ and all other available podcast applications. Amazon Echo owners can also enable access to the podcast through the Almac Podcast skill, then simply asking Alexa to “Play Almac Podcast.”

To learn more about how Almac Clinical Technologies can help to transform your clinical trial, please visit almacgroup.com/clinical-technologies
###

About Almac Group
‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, Interactive Response Technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has organically grown over almost 50 years and now employs close to 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in Europe, the US (Pennsylvania, North Carolina and California) and Asia (Singapore and Tokyo).

To keep up to date with our latest news, follow us on Twitter and LinkedIn.

http://www.almacgroup.com

Read the full story at https://www.prweb.com/releases/almac_clinical_technologies_releases_new_podcast_series_entitled_spotlight_on_irt_best_practices/prweb15647328.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
2. QuickSTAT Partners with Almac Group to Develop a Temperature Controlled Packaging Management System to Strengthen their Global Supply Chain
3. Almac Group Announces Strategic Partnership with inVentiv Health
4. Almac Group Collaborates with Exostar to Extend Clinical Trials with Interactive Response Technology
5. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
6. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
7. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
8. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
9. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
10. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
11. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/3/2018)... N.C. (PRWEB) , ... November 01, 2018 , ... Triangle ... by Inc. Magazine as one of the fastest-growing private companies in the United States, ... Inc. 5000 list ranks private companies based on percentage revenue growth over the previous ...
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers ... of this global competition is to find new and innovative uses of field corn. ... farmers produced 14.6 billion bushels of corn and are on pace to produce the ...
(Date:10/24/2018)... (PRWEB) , ... October 22, 2018 , ... ... for research scientists, clinicians, and medical experts from around the world, will host ... event will focus on best practices in testing, chromatography, centrifugation, as well as ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
Breaking Biology Technology:
(Date:10/26/2018)... , ... October 25, 2018 , ... uBiome, the leader ... the Department of Pathology and Laboratory Medicine at University of California Los Angeles (UCLA), ... around the world, Dr. Braun will bring to uBiome a deep expertise on the ...
(Date:10/24/2018)... ... October 23, 2018 , ... Mitotech S.A., a Luxembourg-based ... a U.S. Phase 3 clinical trial of SkQ1 compound in patients with moderate ... stress within the mitochondria. Visomitin, a topical ophthalmic formulation of this innovative ...
(Date:10/18/2018)... ... October 18, 2018 , ... Drug toxicity is a ... needs to be identified and mitigated. Failure to recognize such toxicities during the ... as well as a serious challenge to drug developers faced with an unforeseen drug ...
Breaking Biology News(10 mins):